PI3K/Akt/mTOR
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20633 | Tersolisib ( STX-478 ) | 2883540-92-7 | ≧98.0% |  |
| Tersolisib ( STX-478 ) 是第二代突变体选择性口服 PI3Ka 小分子变构抑制 | ||||
| 51802 | TIC10 ( ONC201 ) | 1616632-77-9 | 99.85% | _1616632-77-9.png) |
| ONC201 / TIC10是人类TRAIL基因的新型小分子诱导剂，可改善重组TRAIL的 | ||||
| 51902 | AT13148 | 1056901-62-2 | ≧98% |  |
| AT13148, a first-in-class multi-AGC kinase inhibitor, against gastric cancer cells. A | ||||
| 102703 | AZD-8835 | 1620576-64-8 | ≧98.0% |  |
| AZD8835 is a potent and selective inhibitor ofPI3KαandPI3KδwithIC50s of 6.2 and 5.7 | ||||
| 161227116 | Afuresertib HCl | 1047645-82-8 | ≧98.0% |  |
| Afuresertib，也称为GSK2110183，是一种具有潜在抗肿瘤活性的丝氨酸/ | ||||
| 21248 | Giredestrant | 1953133-47-5 | ≧98.0% |  |
| Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally ava | ||||
| 20618 | Pirtobrutinib | 2101700-15-4 | 98% Min. |  |
| 24055 | Palupiprant ( E7046 ) | 1369489-71-3 | ≧98.0% |  |
| E7046 is a potent and selective antagonist of the type 4 prostaglandin E2 (PGE2) rece | ||||
| 24069 | Tuvusertib | 1613200-51-3 | ≧98.0% |  |
| Tuvusertib, also known as M-1774 and ATR inhibitor 1, is a ATR inhibitor. M1774 selec | ||||
| 25085 | Umbralisib | 1532533-67-7 | 98% Min. |  |
| Umbralisib, also known as TGR1202 and RP5264 , is a highly specific, orally available | ||||
| 25094 | Nedisertib ( peposertib ) | 1637542-33-6 | ≧98.0% |  |
| Nedisertib，也称为M-3814，MSC2490484A，是一种口服的DNA依赖性蛋白激酶 | ||||
| 25171 | Alnodesertib ( 同义词: ART0380 ) | 2267316-76-5 | ≧98.0% | .png) |